AstraZeneca CEO Hopes A Post-Trump And Brexit World Won't Damage Pharma

AstraZeneca's CEO Pascal Soriot says change is inevitable for pharma after Donald Trump's election win and the UK's decision to leave the EU and that dialogue with governments will be necessary to ensure key benefits of globalization enjoyed by the sector are retained.